Skip to content
OpenCapital
Get started

4D Molecular Therapeutics FDMT Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + Leisure logo
Travel + LeisureTNL
18.8%+0.1pp
Belden logo
BeldenBDC
12.2%+0.5pp
Cabot Corporation logo
Cabot CorporationCBT
14.7%-6.0pp
Unifirst logo
UnifirstUNF
6.2%-0.9pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
3.4%+1.8pp
Liberty Broadband Corporation logo
Liberty Broadband CorporationLBRDK
-0.3%-0.1pp

Other financials

Income statement

See full
Revenue$3.0M+21,664%
Operating income-$73.6M-37.3%
Net income-$68.8M-43.3%
EPS (diluted)-$1.01-17.4%

Balance sheet

See full
Cash & equivalents$72.5M-45.7%
Total debt$20.5M-13.9%
Total equity$451.8M-3.8%
Total assets$512.9M-0.5%

Cash flow

See full
Operating cash flow-$68.1M-42.6%
CapEx--100%
Free cash flow-$68.1M-40.8%

Valuation

See full
Market cap$602.22M+215%
Enterprise value$550.27M+574%
P/S6.8×-8,306×

Profitability

See full
Operating margin-220.1%-110pp
Net margin-174,314.2%-62,763pp
FCF margin-154,209.2%-53,057pp

Returns & leverage

See full
Return on equity-45.4%+29.8pp
Debt / equity0×0.0×
Current ratio9.3×-3.0×

Where this comes from

Calculated from 4D Molecular Therapeutics’s reported figures.

$20.5Mtotal debt+$451.8Mtotal stockholders equity−$72.5Mcash and equivalents=$399.88M

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 4D Molecular Therapeutics's invested capital?
4D Molecular Therapeutics (FDMT) reported invested capital of $399.88M in Q1 2026.
How has 4D Molecular Therapeutics's invested capital changed year-over-year?
4D Molecular Therapeutics's invested capital increased by 11.1% year-over-year, from $360.05M to $399.88M.
What is the long-term trend for 4D Molecular Therapeutics's invested capital?
Over 5 years (2020 to 2025), 4D Molecular Therapeutics's invested capital has grown at a 191.0% compound annual growth rate (CAGR), from -$2.24M to $466.84M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).